Clinical trial
ReActiv8 Stimulation Therapy vs Optimal Medical Management: A Randomized…
NCT04803214 · Mainstay Medical, Industry · Completed
Key facts
| NCT number | NCT04803214 |
|---|---|
| Title | ReActiv8 Stimulation Therapy vs Optimal Medical Management: A Randomized Evaluation |
| Official title | ReActiv8 Stimulation Therapy vs Optimal Medical Management: A Randomized Evaluation |
| Acronym | RESTORE |
| Lead sponsor | Mainstay Medical, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Chronic Low-back Pain |
| Intervention type | Device |
| Interventions | ReActiv8 |
| Enrollment | 203 |
| Start date | Jul 14, 2021 |
| Primary completion | Sep 4, 2024 |
| Completion | Jan 5, 2026 |
| First posted | Mar 17, 2021 |
| Last update posted | Jan 23, 2026 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: